<DOC>
	<DOCNO>NCT01419457</DOCNO>
	<brief_summary>This study design determine pharmacokinetics favipiravir volunteer hepatic impairment healthy control volunteer .</brief_summary>
	<brief_title>Pharmacokinetics Favipiravir Volunteers With Hepatic Impairment</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Hepatically impaired group : Agree doctor approve birth control method Day 1 3 month follow final dose study drug . Have mild hepatic impairment ( ChildPugh Clinical Assessment Score Grade A , score 5 6 ) moderate hepatic impairment ( ChildPugh Clinical Assessment Score Grade B , score 79 ) severe hepatic impairment ( ChildPugh Clinical Assessment Score Grade C , score 1015 ) ; Control group Agree doctor approve birth control method Day 1 3 month follow final dose study drug . Healthy determine medical history , physical exam , vital sign , ECGs , clinical laboratory test . Hepatically impaired group : Have use drug know significantly affect hepatic metabolism within 28 day , unable unwilling forgo use product throughout study ; Have acute unstable condition disease , impaired hepatic function , determine medical history , physical exam , ECG clinical laboratory test ; Known ongoing alcohol and/or drug abuse within 1 month Any evidence progressive worsening liver function disease indicate laboratory value ; Have acute flare hepatitis A B within 6 month ; Have acute , fulminant alcoholic hepatitis , determine either clinically histology ; Have history hepatoma metastatic disease liver ; Control group : Have use drug know significantly affect hepatic metabolism within 28 day , unable unwilling forgo use product throughout study ; Have history presence clinically cardiovascular , dermatologic , endocrine , gastrointestinal , hematologic , hepatic , immunologic , neurologic , oncologic , psychiatric , pulmonary , renal disease condition .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Healthy</keyword>
	<keyword>hepatic impairment</keyword>
	<keyword>T-705a</keyword>
	<keyword>Favipiravir</keyword>
</DOC>